eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Control of Immediate Precursors Used in Illicit Manufacture of Fentanyl as Schedule II Controlled Substance
Control of Immediate Precursors Used in Illicit Manufacture of Fentanyl as Schedule II Controlled Substance
Document ID:
DEA-2010-0014-0001
Document Type:
Rule
Agency:
Drug Enforcement Administration
Topics:
Administrative Practices and Procedures, Drug Traffic Control, Reporting and Recordkeeping Requirements
CFR Citation:
21 CFR Part 1308
View Document:
Details Information
Document Subtype:
Final Rule
Received Date:
June 29 2010, at 12:00 AM Eastern Daylight Time
Start-End Page:
37295 - 37299
Comment Start Date:
June 29 2010, at 12:00 AM Eastern Standard Time
Comments
Total:
0
No comments posted.
Related Documents
More
Total:
32
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Schedules of Controlled Substances: Placement of Methylone into Schedule I
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I
Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV
Establishment of Drug Codes for 26 Substances
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Schedules of Controlled Substances: Extension of Temporary Placement of Methylone Into Schedule I
Schedules of Controlled Substances: Placement of Methylone into Schedule I
Schedules of Controlled Substances: Placement of Five Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act
Schedules of Controlled Substances: Placement of Ezogabine Into Schedule V
Schedules of Controlled Substances: Placement of Carisoprodol Into Schedule IV
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cathinones Into Schedule I
Schedules of Controlled Substances: Placement of Ezogabine into Schedule V
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cathinones Into Schedule I
Establishment of a New Drug Code for Marihuana Extract
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I; Correction
Schedules of Controlled Substances: Placement of 5-Methoxy-N,N-Dimethyltryptamine into Schedule I of Controlled Substances Act
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I
Listing of Approved Drug Products Containing Dronabinol in Schedule III
Schedules of Controlled Substances: Placement of Propofol into Schedule IV
Schedules of Controlled Substances: Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine into Schedule I of Controlled Substances Act; Correction
Schedules of Controlled Substances: Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine into Schedule I of Controlled Substances Act; Correction
Correction of Code of Federal Regulations: Removal of Temporary Listing of Benzylfentanyl and Thenylfentanyl as Controlled Substances
Schedules of Controlled Substances: Exempted Prescription Product; River Edge Pharmaceutical, Servira
Schedules of Controlled Substances: Placement of Carisoprodol into Schedule IV; Announcement of Hearing
Schedules of Controlled Substances; Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhalers Manufactured by Classic Pharmaceuticals, LLC
Schedules of Controlled Substances: Placement of Fospropofol into Schedule IV
Schedules of Controlled Substances: Placement of Lacosamide into Schedule V
Schedules of Controlled Substances: Placement of Tapentadol into Schedule II
Control of Immediate Precursors Used in Illicit Manufacture of Fentanyl as Schedule II Controlled Substance
Details Information
Comments
Related Documents
More